Evidentli is a software company that specialises in real-world clinical data. Translating the previously incomprehensible, bringing together the historically fragmented, our mission is to empower the world's communities to advance healthcare through data.
David has been a Strategic Advisor to Evidentli for several years. David has held founder, leadership, and advisory roles at more than a dozen digital and AI startups, starting in the late 90s, and has been a Partner focusing on Data and AI-enabled transformation in Health and Life Sciences at professional services firms such as McKinsey, Accenture, Alvarez & Marsal and Infosys. Throughout his career, David has combined his entrepreneurial and advisory roles to pursue a mission of driving sustained performance and outcome improvements for all stakeholders in health and care ecosystems worldwide, with a focus on converting data into actionable insights and enabling collaboration across the ecosystem.
Guy is the Founder and Chief Scientific Officer of Evidentli, and the inventor of Evidentli’s technology. Originally an AI expert from Silicon Valley, Guy has specialized in biomedical AI since 2006, and published over a hundred academic papers. Guy is also an associate editor at two of the three most important scientific journals in digital health: Journal of Biomedical Informatics (Elsevier) and JMIR (JMIR Publishing). Guy also co-leads the FHIR to OMOP harmonization working group at HL7 and OHDSI, is a Fellow of the Australasian Institute for Digital Health, and is a co-founder of the International Collaboration for Automation of Systematic Reviews (ICASR). Guy holds an Adjunct Fellow position at the Centre for Health Informatics at Macquarie University.
Alison brings over 16 years of experience in the Australian Healthcare start-up sector working on family office, venture capital investing and establishing healthcare funds. She is on the board and Research Advisory Committee of the National Foundation for Medical Research and Innovation.
Davera is a nurse informatician and prior to joining the Company she was the HL7 Terminology Service Management Group co-chair and the director of terminology management at the Johns Hopkins University. She has over three decades of experience in health systems analysis and implementing information technology, terminologies and health data standards in human and population health research.
Enrico is a pioneer and key opinion leader in health informatics globally and in Australia. He is the Director for the Centre for Health Informatics and NHMRC Centre for Research Excellence in eHealth at Macquarie University, the founder of the Australian College of Health Informatician and the author of the Guide to Health Informatics. Enrico is one of only 10 past François Grémy Award of Excellence recipients conferred by the International Medical Informatics Association.
Claudia is currently serving on the boards of Ramsay Health Care (Sydney), Prudential Plc (Hong Kong), Quest Global (Singapore), Clariant (Basel) and Lonza. In March 2026 she stepped off the Board of Roche (Basel) where she served since 2016. Across these boards she has assumed roles on audit, compensation, risk and sustainability committees. She has dedicated her career to shaping the future of global healthcare systems, driving innovation at the intersection of healthcare, leadership and change. Previously Claudia was a senior partner at McKinsey in Europe, US and China as sector leader for Asia Health Services and Systems.
Kaveh is a healthcare strategist with extensive experience in digital health, growth strategies and international expansion. He is currently Health Senior Advisor at Accenture, a partner at Guidon Partners advising healthcare service companies and adjunct lectuturer in Health Enterprise Management at the Kellogg School of Management. He was formerly Accenture's Senior Managing Director for Global Health across US, Europe and Asia Pacific. He previously held roles at Cisco, Thompson Reuters and United Healthcare. Kaveh holds an M.D in medicine. One of his many accomplishments was establishing one of the Midwest’s first electronic-health-record-enabled primary care practices. IT Services Report named him in the top 5 healthcare IT executives for 2020 and 2025.
.png)
30 years investment and financial industry experience across venture capital, investment banking, funds management, M&A, corporate and strategic advisory with Goldman Sachs, GS JBWere, Commercial Union Asset Management, Investment Partner at Real VC, CEO Asia Principal Capital, Trustee HEAL Partners Funds. AFSL holder and Compliance Officer for Factory Capital, RealVC and Asia Principal Capital.
Grahame is the Inventor and project lead for data interoperability standard HL7/FHIR. Grahame is the world leading expert on clinical data interoperability, whose work is connecting USA, European and other healthcare data systems.
Ken directs the Computational Health Informatics Program at Boston Children's Hospital and is the Donald A.B. Lindberg Professor of Pediatrics and Biomedical Informatics at Harvard University. He is trained as a pediatrician and pediatric emergency physician and a pioneer in biomedical informatics. Dr. Mandl is a recipient of the Presidential Early Career Award for Scientists and Engineers, the Donald A.B. Lindberg Award for Innovation in Informatics and the Clifford A. Barger Award for top mentors at Harvard Medical School.
Blackford is a physician and health informatics innovator committed to healthcare transformation. As one of the pioneers of digital health, Blackford served on the AHRQ evidence-based Care Transformation Support (ACTS) Roadmap working group and served as Chair of the Steering Committee for the Patient-centered Clinical Decision Support Learning Network. He is past Chairman of the Board of Directors of the American Medical Informatics Association (AMIA), the Healthcare Information Management and Systems Society (HIMSS), and the Computer-based Patient Record Institute (CPRI).
Paul is the director of the Institute for Evidence Based Healthcare, Bond University. His team is building capacity in health services research and does applied research that can be used to improve the efficiency and organisation of health services. Paul is the former director of the Centre for Evidence Based Medicine at Oxford University. He is an NHMRC Senior Research Fellow and the author of many evidence based medicine standards.
Susan is the former CEO of Therapeutic Guidelines: Australia’s biggest publisher of evidence-based recommendations for clinical practice and held executive and change management roles at the National Institute of Clinical Studies, National Health and Medical Research Council. She was awarded an Australia Day Medallion in recognition of her work in closing evidence-practice gaps in Australian health care settings.
Marc is a recognized leader in medical informatics. Currently CEO of the Consortium for State and Regional Interoperability in the US. He was formerly Staff VP Health Informatics and Data Architecture at Elevance Health, CMIO at Cerner Corp and advanced standards integration of electronic health records at Siemens Health. Marc founded the Indiana Health Information Exchange (IHIE), one of the first and most comprehensive health information exchanges in the US. In Marc’s role as Director of Medical Informatics at the Regenstrief Institute and faculty member at Indiana University, he co-led the Observational Medical Outcomes Partnership (OMOP), now a globally recognized initiative in observational health data science.
Bjorn has more than 25 years of international experience across medtech, pharma, biotech and technology. He is currently Chair of NanoEcho AB and APNC Sweden, board member of Industry Commons Foundation and Global South Connect, strategic Advisor to Rethink Capital, Partner at CVX Ventures and Founder of BearInMind. Bjorn has previously held roles at Novo Nordisk, Astra Zeneca and Medtronic.
Farhad is a physician-executive focused on healthcare innovation and impact. He is currently a board member of Medical Insights and Duke U Global Health Institute in the US. He is also a strategic advisor to the Fleming Initiative in UK, QIDA, Verve Capital, and McGill U. Faculty of Medicine. He was formerly Global Head Innovative Commercial Partnerships at Novartis Pharma Division (Basel), Partner Healthcare Advanced Analytics at McKinsey (UK) and Global Head Healthcare Systems at Novartis.
Alex has extensive experience in strategy, value selling, sales ops, R&D, digital transformation and innovation across corporates and start-ups in tech, healthcare, life sciences and insurtech industries. Alex’s current and previous roles include Senior Partner and Strategic Partner Life Sciences Strategy EMEA at Causaly, Senior Director/RVP Business Value Services at Salesforce (UK) and Co-Founder Bupa’s Customer Lab.
Abel is Professor of Medicine and Preventive Medicine in the Northwestern University Feinberg School of Medicine and Founding Director of the Institute for Artificial Intelligence in Medicine. His research focuses on developing novel methods to integrate and analyze diverse data (e.g. electronic health records, administrative data, geospatial data) and the real-world application of privacy enhancing technologies. He is an elected Fellow of the American College of Medical Informatics and recipient of the Donald A.B. Lindbergh Award for Innovation in Informatics.
Matt Lowe is Founder and CEO of performance-io.com and a pharmaceutical digital transformation leader with over 23 years of experience. His performance.io team has helped companies like AstraZeneca, Sanofi, Novo Nordisk, Novartis, Galderma, GSK, and ViiV revolutionize their online engagement model. Matt combines deep industry knowledge with expertise in AI and emerging technologies – optimizing visibility across both traditional and AI-driven search – to drive meaningful engagement with HCPs and patients.
Milind is a globally recognized healthcare and life sciences technology executive, and venture leader with over two decades of experience building and scaling companies and market-leading capabilities at the intersection of life sciences, healthcare, and deep tech. He has co-founded and incubated multiple startups—including ventures at Flagship Pioneering, RA Capital, Arch, and General Catalyst—raising nearly $500M in funding. As the first Chief Data Officer at Sanofi and a senior executive at Novartis, Milind pioneered enterprise AI transformations and forged strategic alliances with Apple, AWS, Microsoft, and Google. He advises boards, CEOs, and VCs across biotech, AI, and venture capital, and has been invited to speak at forums including TEDx, Stanford, Harvard, and the World Economic Forum.
Marcus Vass is a senior Technology and IP lawyer based in London. He is head of Digital Health at international law firm Osborne Clarke LLP and has also worked for 15 years in Beijing and Hong Kong. He is a guest lecturer on the MSc in Translational Health at the University of Oxford and has also taught at Said Business School, Chairman of an AI spin out from Oxford University Innovation and appointed as a board Advisor to companies in Europe and APAC.